Jennifer Pritzker Sells 10,131 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 10,131 shares of the stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $23.10, for a total value of $234,026.10. Following the completion of the sale, the insider owned 6,526,633 shares of the company’s stock, valued at $150,765,222.30. The trade was a 0.15% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Stock Performance

Shares of KIDS stock opened at $22.80 on Thursday. The company has a market capitalization of $595.31 million, a price-to-earnings ratio of -13.57 and a beta of 0.99. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $26.74. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. The stock’s fifty day simple moving average is $21.68 and its 200-day simple moving average is $18.80.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The firm had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. On average, sell-side analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

Large investors have recently made changes to their positions in the company. California State Teachers Retirement System boosted its holdings in OrthoPediatrics by 397.1% in the second quarter. California State Teachers Retirement System now owns 4,553 shares of the company’s stock valued at $87,000 after acquiring an additional 3,637 shares during the last quarter. Nantahala Capital Management LLC bought a new stake in OrthoPediatrics during the 2nd quarter worth about $4,636,002. Grandeur Peak Global Advisors LLC acquired a new position in OrthoPediatrics during the 2nd quarter valued at about $954,000. Bank of America Corp DE acquired a new position in OrthoPediatrics during the 2nd quarter valued at about $268,000. Finally, AWM Investment Company Inc. bought a new position in shares of OrthoPediatrics in the 2nd quarter valued at about $4,537,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

Trending Headlines about OrthoPediatrics

Here are the key news stories impacting OrthoPediatrics this week:

• Positive Sentiment: Wall Street’s consensus rating remains Moderate Buy, with an average price target of $26.44. Piper Sandler maintained an Overweight rating and raised its target to $25, while Needham increased its target to $35 and reiterated Buy. OrthoPediatrics analyst coverage
• Positive Sentiment: Several institutions increased their positions during the first half of the year. Millennium Management raised its stake by 55.3%, Goldman Sachs more than doubled its holdings, and institutional investors collectively own approximately 69.05% of outstanding shares.
• Positive Sentiment: OrthoPediatrics recently exceeded quarterly expectations, reporting revenue of $70.51 million versus the $68.21 million consensus estimate and a loss of $0.26 per share, better than the expected $0.30 loss. This suggests operating results are progressing ahead of forecasts, despite the company remaining unprofitable.
• Neutral Sentiment: The reported transactions appear in multiple director, major-shareholder and beneficial-ownership filings, so some disclosures may represent overlapping ownership records rather than separate sales. The reporting holders still controlled roughly 6.53 million shares after the transactions. SEC ownership filing
• Negative Sentiment: Director David Pelizzon and major shareholder Jennifer N. Pritzker reported sales totaling 326,700 shares on August 28 at an average price of $23.04, worth approximately $7.53 million. The sales reduced reported ownership by 4.76% and may weigh on sentiment by creating an insider-selling overhang.
• Negative Sentiment: The same ownership group also reported sales of 10,131 shares on September 1 at $23.10, valued at about $234,000 per filing. While the 0.15% reduction is modest, the additional selling reinforces the near-term supply concern. OrthoPediatrics insider sale report

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on KIDS. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Needham & Company LLC raised their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Weiss Ratings raised shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Finally, BTIG Research increased their target price on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, OrthoPediatrics has a consensus rating of “Moderate Buy” and an average target price of $26.44.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.